MyJournals Home  

RSS FeedsPharmaceuticals, Vol. 10, Pages 81: Molecular Docking and 3D-Pharmacophore Modeling to Study the Interactions of Chalcone Derivatives with Estrogen Receptor Alpha (Pharmaceuticals)

 
 

16 october 2017 15:42:01

 
Pharmaceuticals, Vol. 10, Pages 81: Molecular Docking and 3D-Pharmacophore Modeling to Study the Interactions of Chalcone Derivatives with Estrogen Receptor Alpha (Pharmaceuticals)
 


Tamoxifen is the most frequently used anti-estrogen adjuvant treatment for estrogen receptor-positive breast cancer. However, it is associated with an increased risk of several serious side-effects, such as uterine cancer, stroke, and pulmonary embolism. The 2´,4´-dihydroxy-6-methoxy-3,5-dimethylchalcone (ChalcEA) from plant leaves of Eugenia aquea, has been found to inhibit the proliferation of MCF-7 human breast cancer cells in a dose-dependent manner, with an IC50 of 74.5 ?g/mL (250 ?M). The aim of this work was to study the molecular interactions of new ChalcEA derivatives formed with the Estrogen Receptor ? (ER?) using computer aided drug design approaches. Molecular docking using Autodock 4.2 was employed to explore the modes of binding of ChalcEA derivatives with ER?. The 3D structure-based pharmacophore model was derived using LigandScout 4.1 Advanced to investigate the important chemical interactions of the ER?-tamoxifen complex structure. The binding energy and the tamoxifen-pharmacophore fit score of the best ChalcEA derivative (HNS10) were -12.33 kcal/mol and 67.07 kcal/mol, respectively. The HNS10 interacted with Leu346, Thr347, Leu349, Ala350, Glu353, Leu387, Met388, Leu391, Arg394, Met421, and Leu525. These results suggest that the new ChalcEA derivatives could serve as the lead compound for potent ER? inhibitor in the fight against breast cancer.


 
121 viewsCategory: Medicine, Pharmacology
 
Pharmaceuticals, Vol. 10, Pages 80: PARP Inhibition by Flavonoids Induced Selective Cell Killing to BRCA2-Deficient Cells (Pharmaceuticals)
Pharmaceuticals, Vol. 10, Pages 82: Electrographic Changes Accompanying Recurrent Seizures under Ketogenic Diet Treatment (Pharmaceuticals)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten